CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Stewart Christopher P. Chief Financial Officer | Grant or award | +105,000 | 231,373 | ||
| 2023-02-15 | Stewart Christopher P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +490,000 | 490,000 | ||
| 2022-08-15 | Linney Yvonne Director | Option exercise | +20,000 | $0.38 | $8K | 20,000 |
| 2022-08-15 | Linney Yvonne Director | Sale | −20,000 | $3.62 | $72K | 0 |
| 2022-08-15 | Linney Yvonne Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 60,923 | ||
| 2022-07-07 | BARKER DAVID L Director | Option exercise | +44,470 | $0.51 | $23K | 58,364 |
| 2022-07-07 | BARKER DAVID L Director | Option exercise · Stock Option (Right to Buy) | −44,470 | 0 | ||
| 2022-06-09 | Rajkovic Aleksandar Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | Mamuszka Hannah Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | Luderer Albert Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | Linney Yvonne Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | BARKER DAVID L Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | Wong Vincent Jung-Fai Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-06-09 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (right to buy) | +164,422 | 164,422 | ||
| 2022-05-16 | BARKER DAVID L Director | Purchase | +10,000 | $1.60 | $16K | 13,894 |
| 2022-05-13 | Stewart Christopher P. Chief Financial Officer | Option exercise | +60,000 | $0.56 | $34K | 121,579 |
| 2022-05-13 | Stewart Christopher P. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −60,000 | 117,500 | ||
| 2022-05-12 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −41,496 | $1.41 | $59K | 216,669 |
| 2022-05-12 | Holmlin R. Erik President and CEO | Shares withheld for taxes | −50,141 | $1.41 | $71K | 538,556 |
Page 6 of 14 · 266 trades